10 participants
Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-02
- Start Date:
- 2026-09-30
- Completion:
- 2029-09-30
Conditions
- Lupus Nephritis
- Lupus Nephritis (LN)
Interventions
- BIOLOGICAL
No Results Yet